Navigating the realm of end-of-life care and access to medications like this drug in New South Wales, Australia, requires a careful grasp of the complex legal framework. Currently, this powerful sedative does not have a recognized place on the Pharmaceutical Benefits Scheme (this program) and is therefore not routinely prescribed by clinical profes